In fact, blockade of IL-6 is the mechanism of action of drugs such as tocilizumab, which is a recombinant humanised anti-human IL-6 receptor monoclonal antibody used in the treatment of rheumatoid arthritis [38]. Here, IL6 is linked to rheumatoid arthritis.